GNG8
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8
Also known as: GBG8_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UK08
- Gene
- GNG8
- Ensembl
- ENSG00000167414
- Chromosome
- 19
- Canonical length
- 70 aa
- Protein class
- Predicted intracellular proteins, RAS pathway related proteins
OverviewNCBI Gene
Predicted to enable G-protein beta-subunit binding activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Predicted to act upstream of or within cellular response to pheromone; nose development; and social behavior. Predicted to be located in plasma membrane. Predicted to be part of heterotrimeric G-protein complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
70 residues, UniProt reviewed canonical sequence.
>Q9UK08|GNG8
1 MSNNMAKIAE ARKTVEQLKL EVNIDRMKVS QAAAELLAFC ETHAKDDPLV TPVPAAENPF
61 RDKRLFCVLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GNG8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 9.4 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 9.4 nTPM
- heart muscle: 5 nTPM
- choroid plexus: 3.9 nTPM
- thymus: 3.9 nTPM
- appendix: 3.1 nTPM
- cerebral cortex: 2.6 nTPM
Single-cell type
- platelets: 192 nCPM
- megakaryocytes: 93 nCPM
- gonadotrophs: 11 nCPM
- adrenal medulla cells: 11 nCPM
- mesothelial cells: 9.2 nCPM
- late spermatids: 7.3 nCPM
Immune cell
- naive B-cell: 5.4 nTPM
- T-reg: 3.2 nTPM
- total PBMC: 2.4 nTPM
- memory B-cell: 1.2 nTPM
- naive CD4 T-cell: 1 nTPM
- neutrophil: 0.9 nTPM
Brain region
- midbrain: 43 nTPM
- white matter: 32 nTPM
- hypothalamus: 30 nTPM
- cerebral cortex: 22 nTPM
- basal ganglia: 20 nTPM
- thalamus: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.68
- gnomAD pLI
- 0.16
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- nervous system development
- nose development
- social behavior
- cellular response to pheromone
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GNG8 as an antibody target. Whether an autoantibody or antibody against GNG8 could matter depends on whether native GNG8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GNG8 is annotated at the cell surface, where native GNG8 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GNG8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...